Xbiotech Inc (NASDAQ:XBIT) Sellers Reduced Their Shorts By 1.51% As Of Jun 29, 2018

June 29, 2018 - By Maria Fierro

XBiotech Inc. (NASDAQ:XBIT) Corporate Logo

Change of 1.51% for Xbiotech Inc (NASDAQ:XBIT)’s shorted shares was showed. It was announced in June by FINRA the 4.45 million shorted shares on XBIT. Previously was reported down change of 1.51% from 4.52M shares. Previous XBIT’s position will need 137 days to restore. It has 32,500 average volume. 22.82% is Xbiotech Inc float short.

The stock increased 1.65% or $0.07 during the last trading session, hitting $4.3.XBiotech Inc. has volume of 3,252 shares. Since June 29, 2017 XBIT has declined 47.21% and is downtrending. XBIT underperformed the S&P500 by 59.78%.

XBiotech Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases.The firm is valued at $152.74 million. The company??s lead product is Xilonix, which is also known as MABp1, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer.Last it reported negative earnings. It has also investigating its lead product candidate in various clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum, and hidradenitis suppurativa, as well as staphylococcus aureus infection, influenza, and clostridium difficile infection diseases.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.